Cargando…

An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall

Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Tatsuki R, Yamashita, Nobuhiro, Furuhata, Ayako, Hirata, Masahiro, Ishida, Takaki, Nakamura, Ichiro, Hirota, Seiichi, Haga, Hironori, Katsuyama, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083143/
https://www.ncbi.nlm.nih.gov/pubmed/24938355
http://dx.doi.org/10.1186/1477-7819-12-186
_version_ 1782324336331325440
author Kataoka, Tatsuki R
Yamashita, Nobuhiro
Furuhata, Ayako
Hirata, Masahiro
Ishida, Takaki
Nakamura, Ichiro
Hirota, Seiichi
Haga, Hironori
Katsuyama, Eiji
author_facet Kataoka, Tatsuki R
Yamashita, Nobuhiro
Furuhata, Ayako
Hirata, Masahiro
Ishida, Takaki
Nakamura, Ichiro
Hirota, Seiichi
Haga, Hironori
Katsuyama, Eiji
author_sort Kataoka, Tatsuki R
collection PubMed
description Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) and negative for KIT, whereas most GISTs are ALK-negative and KIT-positive. Here, we describe a case of a spindle cell tumor in the wall of the urinary bladder. The spindle cells were positive for both ALK and KIT, and it was thus difficult to determine whether the tumor was an IMT or a GIST. We eventually diagnosed an IMT, because ALK gene rearrangement was confirmed by fluorescent in-situ hybridization. Cytoplasmic staining for KIT and the absence of other GIST markers, including DOG1 and platelet-derived growth factor α, indicated that the tumor was not a GIST. Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive.
format Online
Article
Text
id pubmed-4083143
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40831432014-07-08 An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall Kataoka, Tatsuki R Yamashita, Nobuhiro Furuhata, Ayako Hirata, Masahiro Ishida, Takaki Nakamura, Ichiro Hirota, Seiichi Haga, Hironori Katsuyama, Eiji World J Surg Oncol Case Report Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) and negative for KIT, whereas most GISTs are ALK-negative and KIT-positive. Here, we describe a case of a spindle cell tumor in the wall of the urinary bladder. The spindle cells were positive for both ALK and KIT, and it was thus difficult to determine whether the tumor was an IMT or a GIST. We eventually diagnosed an IMT, because ALK gene rearrangement was confirmed by fluorescent in-situ hybridization. Cytoplasmic staining for KIT and the absence of other GIST markers, including DOG1 and platelet-derived growth factor α, indicated that the tumor was not a GIST. Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive. BioMed Central 2014-06-18 /pmc/articles/PMC4083143/ /pubmed/24938355 http://dx.doi.org/10.1186/1477-7819-12-186 Text en Copyright © 2014 Kataoka et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Case Report
Kataoka, Tatsuki R
Yamashita, Nobuhiro
Furuhata, Ayako
Hirata, Masahiro
Ishida, Takaki
Nakamura, Ichiro
Hirota, Seiichi
Haga, Hironori
Katsuyama, Eiji
An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
title An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
title_full An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
title_fullStr An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
title_full_unstemmed An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
title_short An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
title_sort inflammatory myofibroblastic tumor exhibiting immunoreactivity to kit: a case report focusing on a diagnostic pitfall
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083143/
https://www.ncbi.nlm.nih.gov/pubmed/24938355
http://dx.doi.org/10.1186/1477-7819-12-186
work_keys_str_mv AT kataokatatsukir aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT yamashitanobuhiro aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT furuhataayako aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT hiratamasahiro aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT ishidatakaki aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT nakamuraichiro aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT hirotaseiichi aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT hagahironori aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT katsuyamaeiji aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT kataokatatsukir inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT yamashitanobuhiro inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT furuhataayako inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT hiratamasahiro inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT ishidatakaki inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT nakamuraichiro inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT hirotaseiichi inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT hagahironori inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall
AT katsuyamaeiji inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall